| Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine MT Driessen, JM Cohen, SF Thompson, O Patterson-Lomba, ... The Journal of Headache and Pain 23 (1), 56, 2022 | 40 | 2022 |
| Clinical burden and healthcare resource utilization among patients with chronic hypoparathyroidism, overall and by adequately versus not adequately controlled disease: a multi … K Chen, A Krasner, N Li, CQ Xiang, T Totev, J Xie Journal of Medical Economics 22 (11), 1141–52, 2019 | 30 | 2019 |
| Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome DM Halperin, L Huynh, JL Beaumont, B Cai, RH Bhak, S Narkhede, ... BMC Cancer 19 (1), 1-9, 2019 | 22 | 2019 |
| Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study MT Driessen, JM Cohen, O Patterson-Lomba, SF Thompson, M Seminerio, ... The Journal of Headache and Pain 23 (1), 1-15, 2022 | 18 | 2022 |
| Assessment of the impact of a meningitis/encephalitis panel on hospital length of stay: a systematic review and meta-analysis KD Hueth, P Thompson-Leduc, TI Totev, K Milbers, TT Timbrook, N Kirson, ... Antibiotics 11 (8), 1028, 2022 | 17 | 2022 |
| Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to … N Li, X Yang, L Fan, T Totev, A Guerin, L Chen, S Bhattacharyya, ... Journal of Medical Economics 20 (4), 328-336, 2016 | 17 | 2016 |
| Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real‐World Settings: A Multicenter Retrospective Chart Review Study A Dasari, EK Bergsland, AB Benson, B Cai, L Huynh, T Totev, J Shea, ... The Oncologist 24 (8), 1066-1075, 2019 | 12 | 2019 |
| Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma MM Gounder, P Merriam, R Ratan, SR Patel, R Chugh, VM Villalobos, ... Cancer 127 (8), 1311-1317, 2021 | 11 | 2021 |
| Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: a survey study DM Halperin, L Huynh, JL Beaumont, B Cai, T Totev, RH Bhak, MS Duh, ... Medicine 97 (47), e13390, 2018 | 10 | 2018 |
| Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR L Huynh, T Totev, F Vekeman, MP Neary, MS Duh, AB Benson Journal of Medical Economics 20 (9), 945-951, 2017 | 10 | 2017 |
| Understanding the health system conditions affecting the use of long-acting injectable antipsychotics in the treatment of schizophrenia in clinical practice: a US healthcare … M Zhdanava, HL Starr, P Lefebvre, TI Totev, A Shah, K Sheng, D Pilon Neuropsychiatric Disease and Treatment, 1479-1493, 2022 | 9 | 2022 |
| Impact of COVID-19 pandemic on prescribing of long-acting injectable antipsychotics for schizophrenia: results from a United States prescriber survey M Zhdanava, HL Starr, TI Totev, P Lefebvre, A Shah, K Sheng, D Pilon Neuropsychiatric Disease and Treatment, 2003-2019, 2022 | 7 | 2022 |
| Real‐World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study MH Kulke, AB Benson, A Dasari, L Huynh, B Cai, T Totev, N Roesner, ... The Oncologist 24 (8), 1056-1065, 2019 | 7 | 2019 |
| Value of transfusion independence in severe aplastic anemia from patients’ perspectives–a discrete choice experiment AS Pickard, L Huynh, JI Ivanova, T Totev, S Graham, AC Mühlbacher, ... Journal of patient-reported outcomes 2 (1), 13, 2017 | 7 | 2017 |
| Survival and clinical outcomes with telotristat ethyl in patients with carcinoid syndrome DC Metz, E Liu, VN Joish, L Huynh, TI Totev, MS Duh, K Seth, ... Cancer Management and Research, 9713-9719, 2020 | 4 | 2020 |
| A retrospective chart review to assess burden of illness among patients with severe aplastic anemia with insufficient response to immunosuppressive therapy RP De Latour, L Huynh, JI Ivanova, T Totev, M Bilginsoy, JH Antin, A Roy, ... Blood 130, 678, 2017 | 4 | 2017 |
| Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder ZY Zhou, S Sun, P Chopra, Y Zhong, T Totev, J Signorovitch Journal of Medical Economics 18 (11), 919-929, 2015 | 4 | 2015 |
| Assessment of the Impact of a Meningitis/Encephalitis Panel on Hospital Length of Stay: A Systematic Review and Meta-Analysis. Antibiotics 2022, 11, 1028 KD Hueth, P Thompson-Leduc, TI Totev, K Milbers, TT Timbrook, N Kirson, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | 3 | 2022 |
| Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study R Peffault de Latour, L Huynh, JI Ivanova, T Totev, M Bilginsoy, J Antin, ... Annals of hematology 99, 743-752, 2020 | 3 | 2020 |
| Real-world Reductions in Monthly Migraine Days and Migraine-Related Healthcare Resource Utilization in UK Patients Using Fremanezumab S Afridi, TI Totev, LJ Krasenbaum, E Terasawa, H Akcicek, D Dhiraj, ... CEPHALALGIA 42 (1_ SUPPL), 74-75, 2022 | 2 | 2022 |
